| Application no. and date | 14752433.4 (espacenet) (Federated) (European Patent Register), 20140807 | | Patent/reg. no. and date | DK/EP 3033086, 20210922 | | Publication date | 20160622 | | Priority no. and date | US 201361865804 P, 20130814, US 201361894029 P, 20131022 | | EP pub. no. and date |
EP 3033086 20160622 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/165484 | | Inventor | KIM, Sunkyu, c/o Novartis Institutes for BioMedical
Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
CHEN, Yan, c/o Novartis Institutes for BioMedical
Research Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US,
HUANG, Xizhong, c/o Novartis Institutes for BioMedical Research
Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61K 31/551 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombinationsterapi til behandling af cancer | | Int. application no. | IB2014063782 | | Int. publication no. | WO2015022609 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
